Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study

Clinical trial NCT06339138 · COMPLETED

Trial details

NCT number: NCT06339138
Sponsor: Mayo Clinic
Status: COMPLETED
Study type: OBSERVATIONAL

Chromophobe Renal Cell Carcinoma Clear Cell Papillary Renal Tumor Clear Cell Renal Cell Carcinoma Kidney Oncocytoma Papillary Renal Cell Carcinoma Urothelial Carcinoma

Start date: 2018-06-27
Primary completion: 2025-11-12
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.